{
    "2021-04-03": [
        [
            {
                "time": "",
                "original_text": "【华泰金工林晓明团队】招商中证1000投资价值分析",
                "features": {
                    "keywords": [
                        "华泰金工",
                        "林晓明",
                        "招商中证1000",
                        "投资价值分析"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "指数基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "大分子崛起， 小分子落寞！ 千亿市值“原料药之城”何去何从？",
                "features": {
                    "keywords": [
                        "大分子",
                        "小分子",
                        "原料药",
                        "千亿市值"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "近十年30股成基金长期持有的“底仓” 贵州茅台等5股成绝对抱团核心",
                "features": {
                    "keywords": [
                        "近十年",
                        "基金长期持有",
                        "底仓",
                        "贵州茅台",
                        "抱团核心"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费",
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "“A股医药一哥”换了：迈瑞医疗市值反超恒瑞医药",
                "features": {
                    "keywords": [
                        "A股医药",
                        "迈瑞医疗",
                        "恒瑞医药",
                        "市值反超"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}